Updates are available Correction dated 2025-02-05
Click to view Correction: https://doi.org/10.1038/s41551-025-01359-y
-
Authors
Yankaskas, Christopher L.
Thompson, Keyata N.
Paul, Colin D.
Vitolo, Michele I.
Mistriotis, Panagiotis https://orcid.org/0000-0002-8069-3278
Mahendra, Ankit https://orcid.org/0000-0002-6664-5974
Bajpai, Vivek K.
Shea, Daniel J.
Manto, Kristen M.
Chai, Andreas C. https://orcid.org/0000-0001-8651-0164
Varadarajan, Navin
Kontrogianni-Konstantopoulos, Aikaterini
Martin, Stuart S.
Konstantopoulos, Konstantinos https://orcid.org/0000-0003-2623-1459
- License Information
-
More Information
Article History
Received: 15 August 2018
Accepted: 5 April 2019
First Online: 6 May 2019
Change Date: 5 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-025-01359-y
Competing interests
: The PTEN−/− cells are licensed to Horizon Discovery Ltd (Cambridge, UK). M.I.V receives compensation for the sale of these cells. MAqCI is the subject of US Utility Patent applications 15/780,768 and 14/906,055.
